Cargando…
Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions
Coronary artery perforation during percutaneous coronary interventions is a rare but dreaded complication. One of the treatment methods for this complication is the injection of an obliterating material into the ruptured vessel. We will introduce a novel material named “Spongostan” for embolization...
Autores principales: | Hashemi, Arash, Hashemi, Ashkan, Ahmadieh, Arsis, Alizadehasl, Azin, Ansari Ramandi, Mohammad Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892221/ https://www.ncbi.nlm.nih.gov/pubmed/33628517 http://dx.doi.org/10.1155/2021/6688338 |
Ejemplares similares
-
Post-revascularization Ejection Fraction Prediction for Patients Undergoing Percutaneous Coronary Intervention Based on Myocardial Perfusion SPECT Imaging Radiomics: a Preliminary Machine Learning Study
por: Mohebi, Mobin, et al.
Publicado: (2023) -
Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018) -
Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts
por: Hashemi-Jazi, Mohammad, et al.
Publicado: (2017) -
Safety and effect of high dose allopurinol in patients with severe left ventricular systolic dysfunction
por: Ansari-Ramandi, Mohammad Mostafa, et al.
Publicado: (2017) -
Immediate Results and Six-Month Clinical Outcome after Percutaneous Coronary Intervention in Patients with Prior Coronary Artery Bypass Surgery
por: Behboudi, Fatemeh, et al.
Publicado: (2011)